NASDAQ:ZYME - US98985Y1082 - Common Stock
TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 122.87M | 76.30M | 76.01M | 412.50M | 26.70M | |||
Operating Expenses | 205.58M | 196.13M | 214.06M | 282.00M | 242.30M | |||
Research and Development | 143.60M | 134.62M | 143.72M | 208.60M | N/A | |||
Selling, General, and Administrative Expenses | 61.97M | 61.51M | 70.45M | 73.40M | 42.60M | |||
Operating Income | -82.71M | -119.82M | -138.05M | 130.50M | -215.60M | |||
Interest Income/Expense | 15.53M | 20.72M | 18.52M | 4.70M | 3.20M | |||
Other Income/Expense | -247.00K | -218.00K | 291.00K | 0.00 | 100.00K | |||
Non Recurring Items | N/A | -17.29M | N/A | N/A | 0.00 | |||
Income Before Taxes | -67.42M | -116.61M | -119.24M | 135.20M | -212.40M | |||
Income Tax | 6.25M | 6.08M | -568.00K | 10.90M | -500.00K | |||
Net Income | -73.67M | -122.69M | -118.67M | 124.30M | -211.80M | |||
EBITDA | -68.67M | -108.63M | -120.75M | 137.70M | -209.10M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -0.98 | -1.62 | -1.72 | 1.91 | -4.11 | |||
Non GAAP EPS | -0.97 | -1.39 | -1.73 | 1.93 | -4.11 | |||
Statistics | ||||||||
Profit Margin | -59.96% | -160.80% | -156.13% | 30.13% | -793.26% | |||
Operating Profit Margin | -67.32% | -157.03% | -181.62% | 31.64% | -807.49% |
All data in USD